Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2411INDUSTRY 647NIH 109OTHER_GOV 73NETWORK 14FED 9UNKNOWN 5INDIV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Barrett Esophagus 5Carcinoma, Hepatocellular 3Pancreatic Neoplasms 2Colorectal Neoplasms 2Carcinoma in Situ 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Gastroesophageal Reflux 1Fibrosis 1Esophageal Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1Adenocarcinoma 1

Interventions

Everolimus 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDIV × Carcinoma, Hepatocellular × Gastrointestinal × Clear all
NCT05178303 2025-05-16

SB-1121

Trieu, Nguyen Thi, M.D.

Phase 4 Completed
134 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT00775073 2012-04-30

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Treiber, Gerhard

Phase 2 Completed
33 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00440934 2008-05-06

THBC002

Pasche, Boris, M.D.

Phase 2 Terminated
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡